AION Labs, the Israeli innovation lab for startups (see here previously), has helped launch DenovAI – a startup that will harness artificial intelligence and biophysics to build a platform for computer-designed antibodies from the start, geared to the development of … Continue reading →

Tel Aviv University researchers have discovered that the secreted protein LCN2 facilitates the formation of aggressive brain metastases (secondary cancers). In lab tests, reducing LCN2 in the blood halts the advance of the inflammatory process that causes tumors in the … Continue reading →